Raquel Lins
Family · Coeur D Alene, IDNPI 1063199131
Payments from drug & device makers
Across 52 payments — averaging $17.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$184
- Pfizer$142
- Exact Sciences$73
- Novo Nordisk$63
- Lilly USA, LLC$51
- Corcept Therapeutics$49
- plus $360 from 14 others
What the payments were for
- Food & beverage$922100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $184 |
| Pfizer | 13 | $142 |
| Exact Sciences | 3 | $73 |
| Novo Nordisk | 4 | $63 |
| Lilly USA, LLC | 3 | $51 |
| Corcept Therapeutics | 2 | $49 |
| Corium, LLC | 3 | $43 |
| Lundbeck LLC | 2 | $41 |
| Amgen | 1 | $33 |
| Coopersurgical, Inc. | 1 | $28 |
| Boston Scientific | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
| Acadia Pharmaceuticals Inc | 1 | $23 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
| Neurelis, Inc. | 1 | $19 |
| Johnson & Johnson | 1 | $14 |
How this compares
$922 in reported general payments places this provider in the 70th percentile of 809 family providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $15,367 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 11 | $13,187 |
| Levothyroxine Sodium | 106 | $704 |
| Rosuvastatin Calcium | 24 | $539 |
| Omeprazole | 39 | $526 |
| Roflumilast | 13 | $431 |
| Potassium Chloride | 16 | $364 |
| Escitalopram Oxalate | 18 | $284 |
| Atorvastatin Calcium | 37 | $282 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $276 |
| Losartan Potassium | 20 | $149 |
| Metoprolol Succinate | 13 | $142 |
| Amlodipine Besylate | 32 | $112 |
| Simvastatin | 15 | $110 |
| Metformin Hcl | 19 | $72 |
Paid to pharmacies, not to this prescriber.
Other family in Coeur D Alene
- Jennifer WatsonCoeur D Alene$21K
- Julie McCardellCoeur D Alene$10K
- Erika SullivanCoeur D Alene$8K
- Bobbi BullockNampa$609K
- Michael ParkerMeridian$69K
- Jessica BraksiekBoise$41K
- Travis BlaserBoise$33K
- Alysha SchlackNampa$23K
- Amber MasseIdaho Falls$17K
- Brian KittelsonMeridian$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.